Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Lee D. Larcombe
Identification of a Class of Human Cancer Germline Genes With Transcriptional Silencing Refractory to the Hypomethylating Drug 5-Aza-2ˈ-Deoxycytidine
Oncoscience
Cancer Research
Oncology
Related publications
Anticancer Efficacy of Cisplatin and Trichostatin a or 5-Aza-2′-Deoxycytidine on Ovarian Cancer
British Journal of Cancer
Cancer Research
Oncology
DNA Demethylation by 5-Aza-2′-Deoxycytidine Is Imprinted, Targeted to Euchromatin, and Has Limited Transcriptional Consequences
Epigenetics and Chromatin
Genetics
Molecular Biology
Effect of Sulforaphane and 5-Aza-2’-Deoxycytidine on Melanoma Cell Growth
Medicines
Potential Role of 5-Aza-2′-Deoxycytidine Induced MAGE-A4 Expression in Immunotherapy for Anaplastic Thyroid Cancer
Surgery
Surgery
Analysis of the Methylation Status of Genes Up-Regulated by the Demethylating Agent, 5-Aza-2'-Deoxycytidine, in Esophageal Squamous Cell Carcinoma
Oncology Reports
Medicine
Cancer Research
Oncology
Cell Type-Specific Activation of the Cytomegalovirus Promoter by Dimethylsulfoxide and 5-Aza-2'-Deoxycytidine
International Journal of Biochemistry and Cell Biology
Biochemistry
Cell Biology
Resistance to 5-Aza-2'-Deoxycytidine in Genic Regions Compared to Non-Genic Repetitive Sequences
Journal of Reproduction and Development
Animal Science
Zoology
Selinexor, a First-In-Class XPO1 Inhibitor, Is Efficacious and Tolerable in Patients With Myelodysplastic Syndromes Refractory to Hypomethylating Agents
Blood
Biochemistry
Immunology
Cell Biology
Hematology
5-Aza-2′-Deoxycytidine Potentiates Antitumour Immune Response Induced by Photodynamic Therapy
European Journal of Cancer
Cancer Research
Oncology
